Все публикации

0:26:59

Global Health in the Lurch: What’s happening now and who is pushing back?

1:29:08

I Am More Than HIV Prevention – Results from the HPTN 091 Study with Transgender Women

1:22:31

Recording for LEN Gilead Webinar

1:25:44

True Choice in HIV Prevention Involves More than Product Options (Video and English Audio)

1:01:31

An Update on the STI R&D Pipeline and Investments

1:25:46

Launch of the PrEP Ring Early Market Access Vehicle (EMAV)

1:31:54

Regulatory Pathways to Promote Accessibility of STI Diagnostics

1:28:12

Integrating HIV and PrEP Services in US Correctional Facilities

1:12:05

HIVR4P 2024: Daily Debriefs Day 1

0:58:39

HIVR4P 2024: Daily Debriefs Day 2

1:27:59

Innovations of GPP

1:37:41

PrEP Your Booty

1:24:51

Opportunities to Expand Equitable Access to HIV Prevention Services Through Community Pharmacies

1:35:53

Where’s the Equity? Including People with Disabilities in HIV Prevention Programming and Research

1:28:41

Responding to Project 2025’s Threats to Science, Rights and Resources

1:23:25

PrEP Justice: Updates on the US v. Gilead case and the fight for equitable PrEP access

1:25:41

You Get What You Measure: Why Monitoring for PrEP Choice Helps Tell Our Story (in English)

1:20:43

The GPP Body of Evidence: GPP Monitoring and Evaluation Frameworks, REAL and REAL2

1:43:41

It’s Not Just about the Trial: GPP from discovery to delivery in TB research

1:40:09

Lab to the Jab: Lessons learned and what’s next in HIV vaccine research

1:14:43

Sex, Gender & HIV Cure Research

1:29:19

PrEP and the Role of HIV Self-Testing

1:30:41

Just What is Discovery Medicine? And What Does it Mean for HIV Vaccine Research?

1:31:21

We Can’t End HIV in the United States Without Equitable PrEP Access: Strategies for success